Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
about
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NFκB inhibitor.Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer.Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic LeukemiaGenetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.Uncovering the DNA methylome in chronic lymphocytic leukemia.Regulation of hematopoiesis by activators and inhibitors of Wnt signaling from the niche.Molecular pathogenesis of CLL and its evolution.Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors.Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas.Suppression of miR-708 inhibits the Wnt/β-catenin signaling pathway by activating DKK3 in adult B-all.Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor.Wnt signaling in cancer.The expression of SFRP1, SFRP3, DVL1, and DVL2 proteins in testicular germ cell tumors.MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.
P2860
Q34047852-F8ADDFF8-A3C1-49EA-B4A6-AD682EF8BEBFQ35299464-9BE15E01-4F08-4CEE-8FE0-6380C2507F9FQ36088521-9B203053-5E43-4830-820B-362F50DDF492Q36471596-2B3C8A36-FC42-4D05-8387-4D5ACB829A53Q37697850-AC09AED8-EC07-4063-9F59-8796064AA838Q38074267-2C1AB302-37B9-430C-8063-51A777D4E69BQ38194615-AED53217-6E45-4E31-8B7F-C5EDC1F28213Q38335695-7A56FA85-4F5F-4630-B18F-FF22A3D27D5CQ38705028-FFBA5B85-A72E-4155-B394-341CB165BC84Q39432317-6DC7D396-D752-4F5E-86AA-D54EDC52305BQ41940928-00F5E815-A682-41F6-B567-E5ECD41C51EAQ50435067-888032CA-199A-4807-94A0-04798B9EA955Q51518956-70C67403-F8CC-4170-B497-750A0D4BC465Q51531942-234E2504-A403-4E40-A668-9E0FC8A06738Q52577596-21AB1CBF-AB99-4B48-A906-533CC8DB2526
P2860
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@ast
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@en
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@nl
type
label
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@ast
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@en
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@nl
prefLabel
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@ast
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@en
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia.
@nl
P2093
P2860
P921
P356
P1433
P1476
Concurrent epigenetic silencin ...... chronic lymphocytic leukaemia
@en
P2093
Achim Stephan
Aleena A Gladkikh
Evgeny A Moskalev
Ivan A Vorobjev
Kamil D Kaplanov
Katrin Luckert
Marita Schrenk
Olga B Kalashnikova
Oliver Pötz
Thomas O Joos
P2860
P2888
P356
10.1186/1471-2407-12-213
P407
P577
2012-06-06T00:00:00Z
P5875
P6179
1038782256